Search

everythinglearnresearchcommunity

for

Search:↓

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Hormonal imbalances are important in the development of male pattern baldness.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Certain gene variations might be linked to severe acne in women but not in men.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Certain compounds from Kushtakudori ennai may help treat hair loss.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.